Glatiramer acetate-induced hepatitis in a patient with multiple sclerosis

Acta Neurol Belg. 2016 Mar;116(1):99-100. doi: 10.1007/s13760-015-0506-0. Epub 2015 Jul 4.

Authors

A Flaire¹, Clarisse Carra-Dalliere², X Ayrignac¹, P Blanc³, P Labauge¹

Affiliations

¹ Department of Neurology, CHU Montpellier, 80, Avenue Augustin Fliche, 34295, Montpellier, France.
² Department of Neurology, CHU Montpellier, 80, Avenue Augustin Fliche, 34295, Montpellier, France. clarisse.carra@gmail.com.
³ Department of Hepatogastroenterology, CHU Montpellier, Montpellier, France.

PMID: 26141739
DOI: 10.1007/s13760-015-0506-0

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Female
Glatiramer Acetate / adverse effects*
Hepatitis / etiology*
Humans
Immunosuppressive Agents / adverse effects*
Middle Aged
Multiple Sclerosis / drug therapy

Substances

Immunosuppressive Agents
Glatiramer Acetate